Pregnancy and Postpartum CGM in GDM

ID#: NCT07174245

Age: 18 years - 66+

Gender: Female

Healthy Subjects: No

Recruitment Status: Recruiting

Start Date: August 05, 2025

End Date: August 15, 2026

Contact Information:
Shaziah Hassan
212-241-5355
Grenye O'Malley
212-241-7173
Summary: Gestational diabetes (GDM) is one of the most common complications of pregnancy, and up to one third of women with GDM will have abnormal blood sugars after their pregnancy. To screen for abnormal blood sugars, standard of care is a 4-12 week postpartum oral glucose tolerance test (OGTT). However only 17-60% of women actually have this test performed. This study is to assess continuous glucose monitor data from the third trimester and up to 14 days postpartum to find predictors of postpartum OGTT results.
Eligibility:

Inclusion Criteria:

- Diagnosis of gestational diabetes during current pregnancy

- age 18 or older

- prescribed Dexcom G7

Exclusion Criteria:

- Pregestational diabetes

- known skin adhesive allergy which inhibits ongoing use of CGM

- chronic oral steroid use.
Find a Clinical Trial Find Cancer Clinical Trials